Applied Genetic Technologies Corporation logo

Applied Genetic Technologies Corporation Investor Relations Material

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. It focuses on developing adeno-associated virus (AAV)-based gene therapies to treat orphan diseases, including X-linked retinoschisis, achromatopsia, X-linked retinitis pigmentosa, and ocular albinism. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida

Latest company events

Ticker symbol



United States of America

About the company

Investor Relations Page

Dig deeper into the Applied Genetic Technologies Corporation fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot